Device warning letters issued by FDA drop 36% to 417 in FY 1996.
This article was originally published in The Gray Sheet
Executive Summary
FDA DEVICE WARNING LETTERS FALL BY 36% IN FY 1996, reversing a steady upward trend in the number of letters issued by the agency since 1990. The 417 device warning letters issued by FDA's field offices and the Center for Devices and Radiological Health in fiscal 1996 are the fewest since 1991, when the agency sent out about 200 letters.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.